166 related articles for article (PubMed ID: 33676639)
21. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ
Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993
[TBL] [Abstract][Full Text] [Related]
22. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Nucleolin and Associated Genes in Prostate Cancer.
Firlej V; Soyeux P; Nourieh M; Huet E; Semprez F; Allory Y; Londono-Vallejo A; de la Taille A; Vacherot F; Destouches D
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562881
[TBL] [Abstract][Full Text] [Related]
24. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
25. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
26. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
27. Ultrasensitive plasmon enhanced Raman scattering detection of nucleolin using nanochannels of 3D hybrid plasmonic metamaterial.
Shi CF; Li ZQ; Wang C; Li J; Xia XH
Biosens Bioelectron; 2021 Apr; 178():113040. PubMed ID: 33548655
[TBL] [Abstract][Full Text] [Related]
28. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
29. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
[TBL] [Abstract][Full Text] [Related]
30. The cellular protein nucleolin preferentially binds long-looped G-quadruplex nucleic acids.
Lago S; Tosoni E; Nadai M; Palumbo M; Richter SN
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1371-1381. PubMed ID: 27913192
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Separation-Assistant Fluorescence Resonance Energy Transfer Inhibition for Highly Sensitive Probing of Nucleolin.
Li YR; Liu Q; Hong Z; Wang HF
Anal Chem; 2015 Dec; 87(24):12183-9. PubMed ID: 26558409
[TBL] [Abstract][Full Text] [Related]
32. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 Sep; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
33. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
[TBL] [Abstract][Full Text] [Related]
34. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
35. Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Jo J; Bae S; Jeon J; Youn H; Lee G; Ban C
Bioconjug Chem; 2023 Jan; 34(1):238-247. PubMed ID: 36516871
[TBL] [Abstract][Full Text] [Related]
36. G-Quadruplex Aptamer-Ligand Characterization.
Moreira D; Leitão D; Lopes-Nunes J; Santos T; Figueiredo J; Miranda A; Alexandre D; Tomaz C; Mergny JL; Cruz C
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296374
[TBL] [Abstract][Full Text] [Related]
37. Signalling probe displacement electrochemical aptasensor for malignant cell surface nucleolin as a breast cancer biomarker based on gold nanoparticle decorated hydroxyapatite nanorods and silver nanoparticle labels.
Farzin L; Shamsipur M; Samandari L; Sheibani S
Mikrochim Acta; 2018 Feb; 185(2):154. PubMed ID: 29594749
[TBL] [Abstract][Full Text] [Related]
38. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
39. Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411.
Vivanco-Rojas O; García-Bermúdez MY; Iturriaga-Goyon E; Rebollo W; Buentello-Volante B; Magaña-Guerrero FS; Bates P; Pérez-Torres A; Garfias Y
Exp Eye Res; 2020 Apr; 193():107977. PubMed ID: 32081668
[TBL] [Abstract][Full Text] [Related]
40. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
Fan X; Sun L; Wu Y; Zhang L; Yang Z
Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
